Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR 673.60
-20.70 (-2.98%)
At close: Mar 27, 2026
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 132.4 billion as of March 27, 2026. Its market cap has decreased by -16.98% in one year.
Market Cap
132.40B
Enterprise Value
145.82B
Revenue
72.67B
Ranking
n/a
PE Ratio
21.05
Stock Price
673.60
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 132.40B, an increase of 1,370.79%. That is a compound annual growth rate of 20.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 132.40B | -20.40% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 330.39B |
| AstraZeneca Pharma India | 198.65B |
| Granules India | 155.80B |
| Jubilant Pharmova | 133.73B |
| Rubicon Research | 126.50B |
| Caplin Point Laboratories | 118.37B |
| CORONA Remedies | 96.79B |
| Viyash Scientific | 81.72B |